Related Experiment Video
Updated: May 24, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Portable Fluorescence Microarray Reader-Enabled Biomarker Panel Detection System for Point-of-Care Diagnosis of Lupus
Aygun Teymur1, Iftak Hussain2, Chenling Tang1
1Department of Biomedical Engineering, University of Houston, Houston, TX 77024, USA.
A new LED fluorescence reader enables multiplex detection of lupus nephritis biomarkers at the point-of-care. This portable device offers lab-grade accuracy for improved disease monitoring and early intervention.
Area of Science:
- Biomedical Engineering
- Diagnostic Technology
- Point-of-Care Diagnostics
Background:
- Point-of-care (POC) testing offers rapid diagnostics but often lacks sensitivity and multiplexing for complex diseases.
- Lupus nephritis (LN) requires comprehensive biomarker analysis for effective management.
- Existing POC systems may not meet the analytical demands for multi-biomarker detection.
Purpose of the Study:
- To develop and validate an LED-based fluorescence reader for multiplexed POC detection of LN biomarkers.
- To assess the reader's performance against a gold-standard laser scanner.
- To evaluate the potential of this technology for resource-limited settings.
Main Methods:
- An LED fluorescence reader with integrated neutral density filters and onboard image processing was designed.
- A biomarker microarray (BMA) slide was used for multiplex detection of five LN biomarkers.
- Performance was validated using standard curves and patient samples, compared to a Genepix laser scanner.
Main Results:
- The LED reader demonstrated high correlation (r = 0.96-0.98) with the Genepix system.
- Robust signal-to-noise ratios and excellent reproducibility were achieved for all five biomarkers.
- The multiplex format effectively reduced sample volume and enabled simultaneous analysis.
Conclusions:
- The developed LED fluorescence reader provides a portable, cost-effective solution for high-performance POC diagnostics.
- This technology bridges the gap between laboratory precision and POC accessibility for complex diseases like LN.
- It enhances the feasibility of routine monitoring and early intervention, especially in resource-limited environments.
More Related Videos
07:13Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
Published on: June 28, 2024
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020